12:00 AM
 | 
Dec 20, 2010
 |  BC Week In Review  |  Company News  |  Deals

Anaphore, Mitsubishi Tanabe Pharma deal

Mitsubishi Tanabe's Tanabe Research Laboratories U.S.A. Inc. subsidiary partnered with Anaphore to develop trivalent protein therapies to treat autoimmune diseases, including rheumatoid arthritis (RA), inflammatory...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >